Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation

Human Gene Therapy

Volumn 11, Issue 3, 2000, Pages 429-437

  Maruyama, Hiroki ^a   Sugawa, Makoto ^b   Moriguchi, Yoshiyuki ^b   Imazeki, Ikuo ^b   Ishikawa, Yasuko ^b   Ataka, Ken ^a   Hasegawa, Susumu ^a   Ito, Yumi ^a   Higuchi, Noboru ^a   Kazama, Junichiro J ^a   Gejyo, Fumitake ^a   Miyazaki, Jun Ichi ^c  

^a NIIGATA UNIVERSITY   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRITIN; IRON; MESSENGER RNA; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTROPORATION; GENE; GENE TRANSFER; HEMATOCRIT; MALE; MUSCLE; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ELECTROPORATION; ERYTHROPOIESIS; ERYTHROPOIETIN; FERRITINS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HINDLIMB; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAPERITONEAL; IRON; LEUKOCYTE COUNT; MALE; MUSCLE, SKELETAL; PHLEBOTOMY; PLATELET COUNT; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

ANIMALIA;

EID: 0034628485     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050015897     Document Type: Article

References (39)

1. ABRAHAM, N.G., LEVERE, R.D., LIN, J.H.-C., BERU, N., HERMINE, O., and GOLDWASSER, E. (1991). Co-regulation of heme oxygenase and erythropoietin genes. J. Cell. Biochem. 47, 43-48.
2. ABRAHAM, P.A., ST. PETER, W.L., REDIC-KILL, K.A., and HALSTENSON, C.E. (1992). Controversies in determination of epoetin (recombinant human erythropoietin) dosages. Clin. Pharmacokinet. 22, 409-415.
3. AIHARA, H., and MIYAZAKI, J. (1998). Gene transfer into muscle by electroporation in vivo. Nature Biotechnol. 16, 867-870.
4. BERU, N., MCDONALD, J., LACOMBE, C., and GOLDWASSER, E. (1986). Expression of the erythropoietin gene. Mol. Cell Biol. 6, 2571-2575.
5. BOHL, D., and HEARD, J.-M. (1997). Modulation of erythropoietin delivery from engineered muscles in mice. Hum. Gene Ther. 8, 195-204.
6. BOHL, D., NAFFAKH, N., and HEARD, J.-M. (1997). Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nature Med. 3, 299-305.
7. BOHL, D., SALVETTI, A., MOULLIER, P., and HEARD, M. (1998). Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector. Blood 92, 1512-1517.
8. BONDURANT, M.C., and KOURY, M.J. (1986). Anemia induces accumulation of erythropoietin mRNA in the kidney and liver. Mol. Cell. Biol. 6, 2731-2733.
9. DESCAMPS, V., BLUMENFELD, N., VILLEVAL, J.-L., VAINCHENKER, W., PERMICAUDET, M., and BEUZARD, Y. (1994). Erythropoietin gene transfer and expression in adult normal mice: Use of an adenovirus vector. Hum. Gene Ther. 5, 979-985.
10. DESSYPRIS, E.N., GRABER, S.E., KRANTZ, S.B., and STONE, W.J. (1988). Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo. Blood 72, 2060-2062.
11. ESCHBACH, J.W. (1996). Hematological problems of renal failure. In Replacement of Renal Function by Dialysis. C. Jacobs, C.M. Kjellstrand, K.M. Koch and J.F. Winchester, eds. (Kluwer, Dordrecht) pp. 1059-1076.
12. HAMAMORI, Y., SAMAL, B., TIAN, J., and KEDES, L. (1994). Persistent erythropoiesis by myoblast transfer of erythropoietin cDNA. Hum. Gene Ther. 5, 1349-1356.
13. HAMAMORI, Y., SAMAL, B., TIAN, J., and KEDES, L. (1995). Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J. Clin. Invest. 95, 1808-1813.
14. HELLER, R., JAROSZESKI, M., ATKIN, A., MORADPOUR, D., GILBERT, R., WANDS, J., and NICOLAU, C. (1996). In vivo gene electroinjection and expression in rat liver. FEBS Lett. 389, 225-228.
15. KESSLER, P.D., PODSAKOFF, G.M., CHEN, X., MCQUISTON, S.A., COLOSI, P.C., MATELIS, L.A., KURTZMAN, G.J., and BYME, B.J. (1996). Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. U.S.A. 93, 14082-14087.
16. KLINMAN, D.M., CONOVER, J., LEIDEN, J.M., ROSENBERG, A.S., and SECHLER, J.M.G. (1999). Safe and effective regulation of hematocrit by gene gun administration of an erythropoietin-encoding DNA plasmid. Hum. Gene Ther. 10, 659-665.
17. KOURY, M.J., and BONDURANT, M.C. (1990). Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 248, 378-381.
18. MARUYAMA, H., SHIMADA H., OBAYASHI, H., NAKAMARU, T., MIYAKAWA, Y., GOTO, S., OGIHARA, T., TAKAKUWA, K., TANAKA K., KISHIMOTO, H., YUASA, Y., SAKAI, S., OKAJIMA, H., SUZUKI, S., and ARAKAWA, M. (1998). Requiring higher doses of erythropoietin suggests pregnancy in hemodialysis patients. Nephron 79, 413-419.
19. MCDONALD, T.P., CLIFT, R., and COTTRELL, M.B. (1992). Large, chronic doses of erythropoietin cause thrombocytopeni a in mice. Blood 80, 352-358.
20. MURAMATSU, T., MIZUTANI, Y., OHMORI, Y., and OKUMURA, J. (1997). Comparison of three nonviral transfection methods for foreign gene expression in early chicken embryos in ovo. Biochem. Biophys. Res. Commun. 230, 376-380.
21. NAFFAKH, N., HENRI, A., VILLEVAL, J.L., ROUYER-FESSARD, P., MOULLIER, P., BLUMENFELD, N., DANOS, O., VAINCHENKER, W., HEARD, J.M., and BEUZARD, Y. (1995). Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 92, 3194-3198.
22. NAGAO, M., SUGA, H., OKANO, M., MASUDA, S., NARITA, H., IKURA, K., and SASAKI, R. (1992). Nucleotide sequence of rat erythropoietin. Bichim. Biophys. Acta 1171, 99-102.
23. NISHI, T., YOSHIZATO, K., YAMASHIRO, S., TAKESHIMA, H., SATO, K., HAMADA K., KITAMURA, I., YOSHIMURA, T., SAYA, H., KURATSU, J., and USHIO, Y. (1996). High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Res. 56, 1050-1055.
24. NIWA, H., YAMAMURA, K., and MIYAZAKI, J. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-199.
25. OSBORNE, W.R.A., RAMESH, N., LAU, S., CLOWES, M.M., DALE, D.C., and CLOWERS, A.W. (1995). Gene therapy for long-term expression of erythropoietin in rats. Proc. Natl. Acad. Sci. U.S.A. 92, 8055-8058.
26. OSHIMA, Y., SAKAMOTO, T., YAMANAKA, I., NISHI, T., ISHIBASHI, T., and INOMATA, H. (1998). Targeted gene transfer to corneal endothelium in vivo by electric pulse. Gene Ther. 5, 1347-1354.
27. RENDAHL, K.G., LEFF, S.E., OTTEN, G.R., SPRATT, S.K., BOHL, D., ROEY, M.V., DONAHUE, B.A., COHEN, L.K., MANDEL, R.J., DANOS, O., and SNYDER, R.O. (1998). Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nature Biotechnol. 16, 757-761.
28. RIZZUTO, G., CAPPELLETTI, M., MAIONE, D., SAVING, R., LAZZARO, D., COSTA, P., MATHIESEN, I., CORTESE, R., CILIBERTO, G., LAUFER, R., LAMONICA, N., and FATTORI, E. (1999). Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc. Natl. Acad. Sci. U.S.A. 96, 6417-6422.
29. ROLS, M.-P., DELTEIL, C., GOLZIO, M., DUMOND, P., CROS, S., and TEISSIE, J. (1998). In vivo electrically mediated protein and gene transfer in murine melanoma. Nature Biotechnol. 16, 168-171.
30. SETOGUCHI, Y., DANEL, C., and CRYSTAL, R.C. (1994). Stimulation of erythropoiesis by in vivo gene therapy: Physiologic consequences of transfer of the human erythropoietin gene to experimental animals using an adenovirus vector. Blood 84, 2946-2953.
31. SNYDER, R.O., SPRATT, S.K., LAGARDE, C., BOHL, D., KASPAR, B., SLOAN, B., COHEN, L.K., and DANOS, O. (1997). Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum. Gene Ther. 8, 1891-1900.
32. SVENSSON, E.C., BLACK, H.B., DUGGER, D.L., TRIPATHY, S.K., GOLDWASSER, E., HAO, Z., CHU, L., and LEIDEN, J.M. (1997). Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Hum. Gene Ther. 8, 1797-1806.
33. TITOMIROV, A.V., SUKHAREV, S., and KISTANOVA, E. (1991). In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim. Biophys. Acta 1088, 131-134.
34. TRIPATHY, S.K., GOLDWASSER, E., LU, M.M., BARR, E., and LEIDEN, J.M. (1994). Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc. Natl. Acad. Sci. U.S.A. 91, 11557-11561.
35. TRIPATHY, S.K., SVENSSON, E.C., BLACK, H.B., GOLDWASSER, E., MARGALITH, M., HOBART, P.M., and LEIDEN, J.M. (1996). Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc. Natl. Acad. Sci. U.S.A. 93, 10876-10880.
36. ULICH, T.R., DEL CASTILLO, J., and SOUZA, L. (1988). Kinetics and mechanisms of recombinant human granulocyte-colony stimulating factor-induced neutrophilia. Am. J. Pathol. 133, 630-638.
37. WOLFF, J.A., MALONE, R.W., WILLIAMS, P., CHONG, W., ACSADI, G., JANI, A., and FELGNER, P.L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468.
38. WOLFF, J.A., LUDTKE, J.J., ACSADI, G., WILLIAMS, P., and JANI, A. (1992). Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1, 363-369.
39. YE, X., RIVERA, V.M., ZOLTICK, P., CERASOLI, F., JR., SCHNELL, M.A., GAO, G.-P., HUGHES, J.V., GILMAN, M., and WILSON, J.M. (1999). Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 283, 88-91.